Javascript must be enabled to continue!
Portfolio Optimisation and Screening in Low Funding Era
View through CrossRef
Abstract
Portfolio optimisation is the process of choosing the proportions of various assets to be held in a portfolio, in such a way as to make the best use of the opportunities in that portfolio in any prevailing circumstance. This is a component of full-wide portfolio management which is an ill-defined and often over-used term. Whether or not a company's portfolio solution entails consolidating data into a spreadsheet or employing modern portfolio theory to develop an efficient frontier, the goal is to ensure long-term business success by optimising value returns at the minimum risk.
Since June 2014, international oil and gas prices have been declining and currently (Dec 2015) below 40 USD per barrel and 2.5 USD per million Btu respectively (Fig 1). This has brought much pressure on funding availability both on the sides of national and international oil companies.
To fully manage the SPDC's gas portfolio, innovative and sound processes were initiated to optimise and screen a very significant part of our portfolio to ensure that the company still meets and sustains her gas supply obligations with optimal value returns. Prioritisation and ranking of different projects using known parameters and also generating portfolio sensitives using PetroVR tool provided us the foundation for robust decisions on the way forward.
Problem Statement: Evaluate different portfolio options to meet supply agreements and obligations.Prioritise all projects in the portfolio and rank them considering technical, commercial and other non-technical indicators.
The methodologies applied in resolving the above problems were along two work streams namely: Build an integrated gas portfolio model using the PetroVR tool. This was built consistent with latestcompany's operating plan and creating multiple scenarios. The model has production forecasting and economics evaluation/screening capabilities. Therefore, it was possible to check each portfolio scenario in terms of ability to meet gas supply and their economics value.Project prioritisation tool. This is an in-house tool with analytical abilities. Key input data are ultimate recovery, gas Production rate, CAPEX, UDC, NPV, strategic considerations, etc.
The results of these evaluations have helped the company make appropriate decisions on its gas supply strategy and ensuring projects with capacity to meet obligations are matured in priority order.
Title: Portfolio Optimisation and Screening in Low Funding Era
Description:
Abstract
Portfolio optimisation is the process of choosing the proportions of various assets to be held in a portfolio, in such a way as to make the best use of the opportunities in that portfolio in any prevailing circumstance.
This is a component of full-wide portfolio management which is an ill-defined and often over-used term.
Whether or not a company's portfolio solution entails consolidating data into a spreadsheet or employing modern portfolio theory to develop an efficient frontier, the goal is to ensure long-term business success by optimising value returns at the minimum risk.
Since June 2014, international oil and gas prices have been declining and currently (Dec 2015) below 40 USD per barrel and 2.
5 USD per million Btu respectively (Fig 1).
This has brought much pressure on funding availability both on the sides of national and international oil companies.
To fully manage the SPDC's gas portfolio, innovative and sound processes were initiated to optimise and screen a very significant part of our portfolio to ensure that the company still meets and sustains her gas supply obligations with optimal value returns.
Prioritisation and ranking of different projects using known parameters and also generating portfolio sensitives using PetroVR tool provided us the foundation for robust decisions on the way forward.
Problem Statement: Evaluate different portfolio options to meet supply agreements and obligations.
Prioritise all projects in the portfolio and rank them considering technical, commercial and other non-technical indicators.
The methodologies applied in resolving the above problems were along two work streams namely: Build an integrated gas portfolio model using the PetroVR tool.
This was built consistent with latestcompany's operating plan and creating multiple scenarios.
The model has production forecasting and economics evaluation/screening capabilities.
Therefore, it was possible to check each portfolio scenario in terms of ability to meet gas supply and their economics value.
Project prioritisation tool.
This is an in-house tool with analytical abilities.
Key input data are ultimate recovery, gas Production rate, CAPEX, UDC, NPV, strategic considerations, etc.
The results of these evaluations have helped the company make appropriate decisions on its gas supply strategy and ensuring projects with capacity to meet obligations are matured in priority order.
Related Results
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Abstract
Introduction: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the sole curative therapy for myelodysplastic syndromes (MDS). Several studie...
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Background: Lytic bone lesions are one of the most common clinical characteristics of patients with multiple myeloma (MM) and identification of bone lesions help distinguish betwee...
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
BACKGROUND
Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma in which bone marrow is infiltrated by immunoglobulin M (IgM)-producing clonal lymphopl...
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Abstract
BACKGROUND: Autologous stem cell transplantation (ASCT) for multiple myeloma (MM) entails sudden life changes including acute symptom burden, changes in phy...
Robust design optimization of electrical machines for electric and hybrid vehicles
Robust design optimization of electrical machines for electric and hybrid vehicles
Contribution méthodologique au dimensionnement optimal et robuste des machines électriques dédiées aux chaines de traction VE et VEH
Face aux préoccupations croissa...
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Abstract
Background:
GLUT4 inhibition is an attractive therapeutic option in multiple myeloma (MM) given the dependence of MM cells on glucose transpo...
APPROACH SELECTION METHOD FOR PROJECT PORTFOLIO MANAGEMENT AND ITS APPLICATION
APPROACH SELECTION METHOD FOR PROJECT PORTFOLIO MANAGEMENT AND ITS APPLICATION
Project portfolio management has evolved in recent decades from an empirical field to a field with advanced management technologies, including the active use of information technol...
Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,
Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,
Abstract
Abstract 3424
Patients with aplastic anemia (AA) are suffered from various complications related to bone marrow failure and peripheral cytope...

